Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | -- | -- | -- | -- | -- |
| Return | -- | -- | -- | -- | -- | -- |
| Sales | -- | -- | -- | -- | -- | -- |
| Profit | +14.0% | +28.0% | +37.0% | -- | +158.0% | Accelerating |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| OPM % | -33.3% | 40.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Income | 0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | 0 | 0 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Exceptional Items | -- | 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 0.0 | 0.2 | -0.0 | -1.1 | 0.2 | -0.6 | 0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.0 | -0.0 | -0.2 |
| Sales Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Sales Growth (QoQ) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OP Growth (YoY) | 60.0% | 150.0% | 83.3% | 50.0% | 0.0% | 20.0% | -100.0% | -100.0% | -400.0% | 44.4% | -- | -- | -- | -- |
| OP Growth (QoQ) | -200.0% | 300.0% | 0.0% | 80.0% | -25.0% | 33.3% | -200.0% | 60.0% | 0.0% | -66.7% | -200.0% | 0.0% | 88.9% | -- |
| Profit Growth (YoY) | -- | -33.3% | -125.0% | 50.0% | 240.0% | 160.0% | 233.3% | -100.0% | -400.0% | 28.6% | -200.0% | 0.0% | 0.0% | -40.0% |
| EPS Growth (YoY) | -- | 132.8% | -122.2% | -2060.0% | 245.4% | -454.6% | 228.6% | -150.0% | -450.0% | 31.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 1100.0% | 98.2% | -775.0% | 126.2% | -777.8% | 280.0% | 54.5% | 0.0% | -57.1% | -250.0% | 0.0% | 87.5% | -- |
| OP Margin | -- | 40.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Margin | -- | 180.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Material Cost % | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Employee Cost % | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/S | 528.55 | 1162.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50The Stock exchange and stakeholders are requested to take on record outcome of the AGM.
The Stock Exchange and stakeholders are requested to take on record scrutinizer report along with the voting result.
The Stock Exchange and stakeholders are requested to take on record, Newspaper publication made with respect to the Unaudited Financial Result for the quarter ended 30th June, 2026.
The Stock Exchange and Stakeholders are requested to take on record, unaudited Standalone financial Result for the quarter ended 30th June, 2026.
The Stock Exchange and Stakeholders are requested to take on record outcome of the Board Meeting, with respect to the Unaudited financial result for the quarter ended 30th June.
Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the unaudited financial ....
The Stock Exchange and Stakeholders are requested to take on record Annual Report of the Company for the financial year 2025-26
The Stock Exchange and Stakeholders are requested to take on record, Notice of Annual General Meeting.
Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 ,inter alia, to consider and approve The alteration in the ....
Please find attached the compliance certificate as received from our RTA under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30th June, 2026.
The Stock Exchange & Stakeholders are requested to take on record the intimation pertaining to the change in the Registrar & Transfer Agent of the Company.
The Stock Exchange and stakeholders are requested to take on record the Intimation pertaining to the closure of trading window for the unaudited financial results of the Company for the ....
The Stock Exchange and the stakeholder''s are requested to take on record the Newspaper Publication made pertaining to the financial results for the quarter and financial year ended 31st March, 2026.
The Stock Exchange and stakeholders are requested to take on record the Outcome of the Board Meeting, as attached herewith.
The Stock Exchange and Stakeholders are requested to take on record the Outcome of the Board Meeting, as attached herewith.
Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Standalone ....
The Stock Exchange and Stakeholders are requested to take on record the outcome of board meeting held on 05th May, 2026 pertaining to the Change of Registrar & Share Transfer Agent (RTA)
The Exchange and Stakeholders are requested to take on record the intimation under Regulation 30 of SEBI (LODR) pertaining to the change in Registrar & Share Transfer Agent of the Company.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Please find attached the compliance certificate as received from our RTA under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 31st March, 2026.
Please find attached the outcome of board meeting held today i.e., 03rd April, 2026
Please find attached the intimation pertaining to the appointment of Company Secretary and Compliance Officer of the Company.
Please find attached the intimation for the closure of trading window for the purpose of audited financial results of the Company for the quarter and year ended 31st March, 2026.
Please find attach intimation for new corporate office of company.
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the ....
The Stock Exchange and all stakeholders are hereby requested to kindly take on record the Intimation pertaining to the shifting of the Registered Office of the Company, along with the updated ....
The Stock Exchange and all stakeholders are hereby requested to kindly take on record the Outcome of the Board Meeting pertaining to the shifting of the Registered Office of the Company, ....
Newspaper Publication of financial results for the quarter ended 31.12.25
Stock Exchange and the Stakeholders are requested to take on record unaudited financial results for the quarter ended 31st December, 2025.
We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Friday, 13th February, 2026, has, inter alia, considered and approved the unaudited standalone ....
Bonanza Portfolio Limited ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Advertisement under Regulation 18(12) in terms of SEBI (Substantial Acquisition of Shares and ....
Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Stock Exchange and Stakeholders are requested to take on record, Intimation with respect to the resignation of Director o the Company.
Stock- Exchange and Stakeholder are requested to take on record intimation with respect to the resignation of Compliance Officer of the Company
Bonanza Portfolio Limited ("Manager to the Offer") has submitted to BSE a copy of corrigendum to Letter of Offer for the attention of the Shareholders of Shentracon Chemicals Ltd ("Target Company").
Bonanza Portfolio Limited ("Manager to the Offer") has submitted to BSE a copy of Pre-offer advertisement and corrigendum to the detail public statement, in accordance with Regulation 18(7) ....
Stock Exchange and Stakeholder''s are requested to take on record , Certificate under Reg 74(5) of SEBI DP regulation , 2018
Bonanza Portfolio Limited ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors ('IDC') of Shentracon Chemicals Ltd ("Target ....
Bonanza Portfolio Limited ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer to the Shareholders of Shentracon Chemicals Ltd ("Target Company").
Stock -Exchange and Stakeholders are requested to take on record, Intimation with respect to the Closure of trading window for the Quarter ended 31st December, 2025
Please find attached the resignation letters received from the Independent Directors of the Company dated 28th November, 2025.
Please find attached the intimation with respect to resignation of Directors of the Company.
Please find attached the intimation with regards to resignation of Manager/KMP of the Company.
Please find attached herewith the intimation with respect to resignation of Directors and KMP of the Company.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Amit Jain & Hanish Jain
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Savitri Devi Sureka & Others
The board approved the un-audited financial results for the quarter and half year ended on 30-09-2025 in the meeting held today on 08-11-2025.
Approved the un-audited financial results for the quarter and half year ended 30-09-2025
Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve the unaudited financial ....
Please find the attached Outcome of Board meeting without Intimation dated Friday, 24th October, 2025